Biolife Solutions (BLFS) Cost of Revenue (2010 - 2026)

Biolife Solutions (BLFS) has reported Cost of Revenue for 17 consecutive years, with $10.0 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Cost of Revenue rose 37.91% year-over-year to $10.0 million; the TTM figure through Mar 2026 stood at $41.3 million (up 17.99% YoY), while the FY2025 annual figure was $34.1 million, up 38.88% from the prior year.
• Cost of Revenue slipped to $10.0 million in Q1 2026 per BLFS's latest filing, from $31.3 million in the prior quarter.
• Across five years, Cost of Revenue topped out at $31.3 million in Q4 2025 and bottomed at -$4.5 million in Q4 2022.
• Historically, Cost of Revenue has averaged $6.2 million across 5 years, with a median of $1.9 million in 2022.
• Annual changes were most pronounced in 2022 — Cost of Revenue tumbled 116.87% — and 2023, when it jumped 438.59%.
• Biolife Solutions' Cost of Revenue stood at -$4.5 million in 2022, then surged by 438.59% to $15.1 million in 2023, then jumped by 44.55% to $21.8 million in 2024, then jumped by 43.49% to $31.3 million in 2025, then sank by 68.0% to $10.0 million in 2026.
• Business Quant data shows BLFS's Cost of Revenue at $10.0 million in Q1 2026, $31.3 million in Q4 2025, and $7000.0 in Q3 2025.